STRATA Skin Sciences (SSKN) Equity Average (2011 - 2025)

STRATA Skin Sciences has disclosed Equity Average across 15 years of filings, most recently posting $2.1 million for Q4 2025.

• Equity Average for Q4 2025 came in at $2.1 million, down 70.63% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.1 million (down 70.63% YoY), and the FY2025 annual result was $3.9 million, down 55.38% from the prior year.
• Equity Average came in at $2.1 million for Q4 2025 at STRATA Skin Sciences, up from $923000.0 in the prior quarter.
• In the past five years, Equity Average ranged from a high of $26.0 million in Q3 2021 to a low of $923000.0 in Q3 2025.
• The 5-year median for Equity Average is $17.3 million (2023), against an average of $15.4 million.
• Across the five-year window, Equity Average decreased 0.43% in 2021 and slumped 90.24% in 2025, its largest moves.
• STRATA Skin Sciences' Equity Average stood at $25.8 million in 2021, then retreated by 15.44% to $21.8 million in 2022, then sank by 33.81% to $14.4 million in 2023, then slumped by 50.23% to $7.2 million in 2024, then slumped by 70.63% to $2.1 million in 2025.
• The last three Equity Average figures came in at $2.1 million (Q4 2025), $923000.0 (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.